Sign up to save your podcasts
Or
Share Are We Ready for More BTK Inhibitors in Chronic Lymphoblastic Leukemia? Experts Discuss the Latest Data
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Are We Ready for More BTK Inhibitors in Chronic Lymphoblastic Leukemia? Experts Discuss the Latest Data
Did you know that noncovalent Bruton tyrosine kinase (BTK) inhibitors are a potential solution to overcome the challenge of covalent BTK inhibitor resistance in chronic lymphoblastic leukemia (CLL)?
Credit available for this activity expires: 8/24/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979645?src=mkm_podcast_addon_979645
View all episodes
By Medscape
4.3
2323 ratings
Did you know that noncovalent Bruton tyrosine kinase (BTK) inhibitors are a potential solution to overcome the challenge of covalent BTK inhibitor resistance in chronic lymphoblastic leukemia (CLL)?
Credit available for this activity expires: 8/24/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979645?src=mkm_podcast_addon_979645
More shows like Keeping Current CME
View all
The Bob Harrington Show
13 Listeners
NEJM This Week
315 Listeners
Diabetes Core Update
107 Listeners
JACC This Week
171 Listeners
This Week in Cardiology
868 Listeners
JAMA Clinical Reviews
497 Listeners
AFP: American Family Physician Podcast
688 Listeners
One-on-One with Eric Topol
18 Listeners
Mayo Clinic Talks
278 Listeners
Frankly Speaking About Family Medicine
258 Listeners
The Curbsiders Internal Medicine Podcast
3,323 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,103 Listeners
The Peter Attia Drive
8,005 Listeners
Annals On Call Podcast
195 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners
The Cribsiders
313 Listeners